Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-29

FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for the generic Diclofenac Sodium/Misoprostol product from Micro Labs Limited, authorizing its marketing in the United S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac sodium misoprostol (diclofenac sodium and misoprostol)

Snippet

SUPPL AP for DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL (DICLOFENAC SODIUM/MISOPROSTOL)